Artichoke

Artichoke (Cynara scolymus) is a perennial thistle native to the Mediterranean region, cultivated for its edible flower buds and used in traditional herbal medicine for centuries. The leaves of the artichoke plant contain bioactive compounds including cynarin, chlorogenic acid, luteolin, and caffeoylquinic acids, which are believed to support digestive function and bile production.

For private-label supplement brands, artichoke offers a well-recognised botanical positioning around liver and digestive wellness. Its traditional use profile resonates with consumers seeking natural approaches to post-meal comfort and detoxification support. While no EU-authorised health claims are available for artichoke as a standalone botanical, it can be co-formulated with nutrients that carry authorised claims under Reg. 432/2012.

Origin and history

Artichoke has been cultivated and consumed as a food and medicine since ancient Greek and Roman times. The plant was prized for its digestive properties and was traditionally used to support liver function and bile flow. By the 16th century, artichoke had spread throughout Europe and became a staple in Mediterranean cuisine and folk medicine.

Modern commercial production of artichoke for supplements typically involves harvesting the leaves, drying them, and extracting the active compounds using water or ethanol. Standardised extracts are produced to guarantee consistent levels of marker compounds such as cynarin or chlorogenic acid. The majority of artichoke leaf extract used in European supplements is sourced from Mediterranean growing regions including Italy, France, and Spain.

Scientific overview

The primary bioactive compounds in artichoke leaf extract are caffeoylquinic acids, particularly cynarin and chlorogenic acid. These compounds are believed to stimulate bile production and flow from the liver, which supports the digestion of fats and the elimination of waste products. Artichoke also contains flavonoids such as luteolin and apigenin, which contribute to its antioxidant properties.

Bioavailability of artichoke polyphenols is moderate, with peak plasma concentrations occurring 1-2 hours after oral administration. Standardised extracts with defined cynarin or chlorogenic acid content provide more consistent dosing than whole-leaf powder. The bitter taste of artichoke compounds can present formulation challenges in gummy formats, requiring careful flavour masking.

From a manufacturing perspective, artichoke extract is heat-stable and soluble in gummy matrices, making it suitable for gummy production. The cost per serving is moderate compared to other botanical extracts. DAT reviews the specific extract form and standardisation level per project to ensure optimal formulation and stability.

Artichoke occupies a strong position in the digestive health and liver support supplement categories. It is one of the most familiar and commercially understood botanical actives across EU and US markets. Brands use artichoke to target consumers interested in post-meal wellness, detoxification support, and healthy cholesterol metabolism. The ingredient pairs well with other liver-supporting botanicals like Milk Thistle and Turmeric.

From a formulation perspective, artichoke extract integrates well into gummy formats. It is heat-stable and soluble, though its slightly bitter taste requires attention to flavour masking. DAT recommends using standardised extracts for consistent dosing and stability. The moderate cost tier makes artichoke accessible for mid-range product positioning.

For pack copy, brands must observe strict claim discipline. As a botanical on the EU on-hold list, no authorised health claims are currently permitted for artichoke under Reg. 432/2012. Brands may position around traditional use or co-formulate with nutrients that carry authorised claims. DAT reviews all claim wording per project and market to ensure compliance with EU and UK regulations.